Xinqiao Hospital of Chongqing
2 clinical trials · 2 recruiting · OTHER
Trials by Xinqiao Hospital of Chongqing
RECRUITINGNCT05754203
Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
Investigators intend to combine low-dose hypersensitivity with high-dose immunopotentiation effect, and use super-hyperfractionation pulse radiotherapy, which is expected to...
Sponsor: Xinqiao Hospital of ChongqingEnrolling: 402 locations
Lung CancerImmune Checkpoint InhibitorRadiotherapy
RECRUITINGPhase 2NCT06279351
Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
1. To verify that thalidomide can increase the efficacy of cetuximab plus chemotherapy in the treatment of stage IV RAS and BRAF wild-type unresectable left colorectal cancer,...
Sponsor: Xinqiao Hospital of ChongqingEnrolling: 961 location
Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer